Prospective Evaluation of Azacitidine Maintenance Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

被引:0
|
作者
Gill, Harinder [1 ]
Lie, Albert Kwok Wai [1 ]
Kwong, Yok Lam [1 ]
Leung, Anskar Y. H. [1 ]
机构
[1] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] TP53 Mutations In Patients With High-Risk Acute Myeloid Leukemia Treated With Allogeneic Hematopoietic Stem Cell Transplantation
    Middeke, Jan Moritz
    Herold, Silvia
    Ruecker-Braun, Elke
    Mohr, Brigitte
    Berdel, Wolfgang E.
    Kaufmann, Martin
    Schaefer-Eckart, Kerstin
    Baldus, Claudia D.
    Stuhlmann, Reingard
    Heidenreich, Falk
    Stoelzel, Friedrich
    Roellig, Christoph
    Platzbecker, Uwe
    Ehninger, Gerhard
    Bornhaeuser, Martin
    Thiede, Christian
    Schetelig, Johannes
    BLOOD, 2013, 122 (21)
  • [32] Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors
    Liberatore, Carmine
    Stanghellini, Maria Teresa Lupo
    Lorentino, Francesca
    Vago, Luca
    Carrabba, Matteo Giovanni
    Greco, Raffaella
    Marktel, Sarah
    Assanelli, Andrea
    Farina, Francesca
    Corti, Consuelo
    Bernardi, Massimo
    Peccatori, Jacopo
    Sockel, Katja
    Middeke, Jan Moritz
    Schetelig, Johannes
    Bergmann, Anika
    Rautenberg, Christina
    Ciceri, Fabio
    Bornhaeuser, Martin
    Schroeder, Thomas
    Stoelzel, Friedrich
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [33] Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
    Xuan, Li
    Liu, Qifa
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [34] Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
    Li Xuan
    Qifa Liu
    Journal of Hematology & Oncology, 14
  • [35] Sequential allogeneic stem cell transplantation in high risk acute myeloid leukaemia and myelodysplastic syndrome
    Zavrelova, A.
    Radocha, J.
    Lanska, M.
    Zak, P.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S526 - S526
  • [36] Pharmacologic maintenance strategies following allogeneic hematopoietic cell transplantation for acute myeloid leukemia
    Lee, Catherine J.
    Shiraz, Parveen
    Muffly, Lori
    LEUKEMIA & LYMPHOMA, 2017, 58 (03) : 516 - 527
  • [37] Azacitidine and prophylactic donor lymphocyte infusions after hematopoietic stem cell transplantation for pediatric high-risk acute myeloid leukemia
    Huschart, Emily
    Miller, Holly
    Salzberg, Dana
    Campbell, Courtney
    Beebe, Kristen
    Schwalbach, Charlotte
    Magee, Kyrie
    Adams, Roberta H.
    Ngwube, Alexander
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2021, 38 (02) : 154 - 160
  • [38] Stem cell therapy - indications to allogeneic transplantation in myelodysplastic syndrome and acute myeloid leukemia
    Beelen, D. W.
    ONKOLOGIE, 2012, 35 : 110 - 111
  • [39] Role of iron overload for the outcome of allogeneic stem cell transplantation in high-risk acute myeloid leukaemia and myelodysplastic syndrome
    Schmid, C.
    Koenecke, C.
    Wittmann, G.
    Tischer, J.
    Behr, W.
    Eder, M.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S85 - S85
  • [40] Safety and Efficacy of Azacitidine and Chidamide Maintenance after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with High-Risk Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase II Clinical Trial
    Yang, Chuting
    Zheng, Yaling
    Song, Chaoyang
    Wu, Ming
    Wang, Lei
    Zhou, Xuan
    Yue, Chunyan
    Lin, Xiaonan
    Chen, Jie
    Zeng, Hui
    Huang, Rui
    Li, Yuhua
    BLOOD, 2023, 142